Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study

BACKGROUND: Second line anti-tuberculosis drugs are substantially complex, long term, more costly, and more toxic than first line anti-tuberculosis drugs. In Ethiopia, evidence on the incidence and predictors of adverse drug events has been limited. Thus, this study aimed at assessing incidence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Merid, Mehari Woldemariam, Gezie, Lemma Derseh, Kassa, Getahun Molla, Muluneh, Atalay Goshu, Akalu, Temesgen Yihunie, Yenit, Melaku Kindie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437856/
https://www.ncbi.nlm.nih.gov/pubmed/30917788
http://dx.doi.org/10.1186/s12879-019-3919-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437856/
https://www.ncbi.nlm.nih.gov/pubmed/30917788
http://dx.doi.org/10.1186/s12879-019-3919-1

Ejemplares similares